Canadian Cannabis Producer Sundial Prices 11 Million Share NASDAQ IPO at $13


Sundial Announces Pricing of Upsized Initial Public Offering

CALGARY, July 31, 2019 /CNW/ – Sundial Growers Inc. (“Sundial” or the “Company”) today announced the pricing of its upsized initial public offering of 11,000,000 common shares at a price to the public of US$13.00 per share. In addition, the underwriters have been granted a 30-day over-allotment option to purchase up to 1,650,000 additional common shares.

The Nasdaq Global Select Market, or the Nasdaq, in the United States has approved the listing of the common shares. The common shares are expected to begin trading on the Nasdaq on August 1, 2019 under the ticker “SNDL”. The initial public offering is expected to close on August 6, 2019, subject to the satisfaction of customary closing conditions.

Cowen, BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers for the IPO. Barclays and CIBC Capital Markets are acting as bookrunners and Scotiabank is acting as co-manager for the IPO.

Copies of the U.S. prospectus, when available, may be obtained from the SEC’s website or from Cowen, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by email to or by telephone at 833-297-2926. Copies of the Canadian prospectus, when available, may be obtained from or from BMO Capital Markets, Brampton Distribution Centre c/o The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by telephone at (905) 791-3151 Ext 4312 or by email at or RBC Capital Markets, 180 Wellington Street West, 8th Floor, Toronto, ON M5J 0C2, Attention: Simon Yeung, or via telephone: (416) 842-5349, or via email at

The offering will be made only by means of a prospectus.

A registration statement relating to these securities has been filed with, and been declared effective by, the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The Company has obtained a receipt for a final base PREP prospectus filed with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada, except Quebec, on July 30, 2019. A copy of the supplemented PREP prospectus containing pricing information and other important information relating to the common shares may, when available, be obtained from the underwriters at the addresses set out above and will be available on the SEDAR website at under the Company’s profile. Investors should read the prospectus before making an investment decision.

No securities regulatory authority has either approved or disapproved of the contents of this press release.

About Sundial Growers Inc.

Sundial proudly crafts pioneering cannabis brands to Heal, Help and PlayTM:

  • Heal – cannabis products used as prescription medicine
  • Help – cannabis products that strive to promote overall health and wellness through cannabinol (CBD)
  • Play – cannabis products to enhance social, spiritual and recreational occasions

Sundial operates five facilities, including two facilities in Alberta and three in the United Kingdom, and is currently building a third Canadian facility in British Columbia.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter